{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:27:53Z","timestamp":1788294473949,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>New biomarkers to identify cardiovascular disease (CVD) risk earlier in its course are needed to enable targeted approaches for primordial prevention. We evaluated whether intraindividual changes in blood metabolites in response to an oral glucose tolerance test (OGTT) may provide incremental information regarding the risk of future CVD and mortality in the community.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An OGTT (75\u00a0g glucose) was administered to a subsample of Framingham Heart Study participants free from diabetes (n\u2009=\u2009361). Profiling of 211 plasma metabolites was performed from blood samples drawn before and 2\u00a0h after OGTT. The log2(post\/pre) metabolite levels (\u0394metabolites) were related to incident CVD and mortality in Cox regression models adjusted for age, sex, baseline metabolite level, systolic blood pressure, hypertension treatment, body mass index, smoking, and total\/high-density lipoprotein cholesterol. Select metabolites were related to subclinical cardiometabolic phenotypes using Spearman correlations adjusted for age, sex, and fasting metabolite level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our sample included 42% women, with a mean age of 56\u2009\u00b1\u20099\u00a0years and a body mass index of 30.2\u2009\u00b1\u20095.3\u00a0kg\/m<jats:sup>2<\/jats:sup>. The pre- to post-OGTT changes (\u0394metabolite) were non-zero for 168 metabolites (at FDR\u2009\u2264\u20095%). A total of 132 CVD events and 144 deaths occurred during median follow-up of 24.9\u00a0years. In Cox models adjusted for clinical risk factors, four \u0394metabolites were associated with incident CVD (higher glutamate and deoxycholate, lower inosine and lysophosphatidylcholine 18:2) and six \u0394metabolites (higher hydroxyphenylacetate, triacylglycerol 56:5, alpha-ketogluturate, and lower phosphatidylcholine 32:0, glucuronate, N-monomethyl-arginine) were associated with death (P\u2009&lt;\u20090.05). Notably, baseline metabolite levels were not associated with either outcome in models excluding \u0394metabolites. The \u0394metabolites exhibited varying cross-sectional correlation with subclinical risk factors such as visceral adiposity, insulin resistance, and vascular stiffness, but overall relations were modest. Significant \u0394metabolites included those with established roles in cardiometabolic disease (e.g., glutamate, alpha-ketoglutarate) and metabolites with less defined roles (e.g., glucuronate, lipid species).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Dynamic changes in metabolite levels with an OGTT are associated with incident CVD and mortality and have potential relevance for identifying CVD risk earlier in its development and for discovering new potential therapeutic targets.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01647-w","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T12:03:09Z","timestamp":1665835389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community"],"prefix":"10.1186","volume":"21","author":[{"given":"Daniel","family":"Gonzalez Izundegui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura E.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary F.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Gerszten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Nayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"issue":"10","key":"1647_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.113.008506","volume":"130","author":"S Cheng","year":"2014","unstructured":"Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the atherosclerosis risk in communities study. Circulation. 2014;130(10):820\u20138.","journal-title":"Circulation"},{"issue":"19","key":"1647_CR2","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1001\/jama.2009.1698","volume":"302","author":"AD Hingorani","year":"2009","unstructured":"Hingorani AD, Psaty BM. Primary prevention of cardiovascular disease: time to get more or less personal? JAMA. 2009;302(19):2144\u20135.","journal-title":"JAMA"},{"issue":"11","key":"1647_CR3","first-page":"e563","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation. 2019;140(11):e563\u201395.","journal-title":"Circulation"},{"issue":"25","key":"1647_CR4","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the gbd 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"1647_CR5","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1161\/CIRCULATIONAHA.121.057125","volume":"144","author":"DM Lloyd-Jones","year":"2021","unstructured":"Lloyd-Jones DM, Albert MA, Elkind M. The american heart association\u2019s focus on primordial prevention. Circulation. 2021;144(15):e233\u20135.","journal-title":"Circulation"},{"issue":"9","key":"1647_CR6","doi-asserted-by":"publisher","first-page":"e002275","DOI":"10.1161\/JAHA.115.002275","volume":"4","author":"K Liu","year":"2015","unstructured":"Liu K, Colangelo LA, Daviglus ML, Goff DC, Pletcher M, Schreiner PJ, et al. Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels?: The coronary artery risk development in young adults (CARDIA) study and the multi-ethnic study of atherosclerosis (MESA). J Am Heart Assoc. 2015;4(9):e002275.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1647_CR7","doi-asserted-by":"publisher","first-page":"e019695","DOI":"10.1161\/JAHA.120.019695","volume":"10","author":"K Liu","year":"2021","unstructured":"Liu K, Wilkins JT, Colangelo LA, Lloyd-Jones DM. Does lowering low-density lipoprotein cholesterol with statin restore low risk in middle-aged adults? Analysis of the observational mesa study. J Am Heart Assoc. 2021;10(11):e019695.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1647_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.117.027362","volume":"136","author":"GS Tajeu","year":"2017","unstructured":"Tajeu GS, Booth JN 3rd, Colantonio LD, Gottesman RF, Howard G, Lackland DT, et al. Incident cardiovascular disease among adults with blood pressure <140\/90 mm Hg. Circulation. 2017;136(9):798\u2013812.","journal-title":"Circulation"},{"issue":"18","key":"1647_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, H\u00e4m\u00e4l\u00e4inen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343\u201350.","journal-title":"N Engl J Med"},{"issue":"4","key":"1647_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u201353.","journal-title":"Nat Med"},{"issue":"5","key":"1647_CR11","doi-asserted-by":"publisher","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","volume":"5","author":"WE Gall","year":"2010","unstructured":"Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE. 2010;5(5):e10883.","journal-title":"PLoS ONE"},{"issue":"10","key":"1647_CR12","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1172\/JCI64801","volume":"123","author":"TJ Wang","year":"2013","unstructured":"Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Investig. 2013;123(10):4309\u201317.","journal-title":"J Clin Investig"},{"issue":"4","key":"1647_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121(4):1402\u201311.","journal-title":"J Clin Invest"},{"issue":"4","key":"1647_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9(4):311\u201326.","journal-title":"Cell Metab"},{"issue":"6427","key":"1647_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aav0558","volume":"363","author":"PJ White","year":"2019","unstructured":"White PJ, Newgard CB. Branched-chain amino acids in disease. Science. 2019;363(6427):582\u20133.","journal-title":"Science"},{"issue":"2","key":"1647_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/HYPERTENSIONAHA.116.07292","volume":"68","author":"S Dietrich","year":"2016","unstructured":"Dietrich S, Floegel A, Weikert C, Prehn C, Adamski J, Pischon T, et al. Identification of serum metabolites associated with incident hypertension in the european prospective investigation into cancer and nutrition-potsdam study. Hypertension. 2016;68(2):471\u20137.","journal-title":"Hypertension"},{"issue":"2","key":"1647_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","volume":"3","author":"SH Shah","year":"2010","unstructured":"Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, Haynes C, et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet. 2010;3(2):207\u201314.","journal-title":"Circ Cardiovasc Genet"},{"issue":"7341","key":"1647_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature"},{"key":"1647_CR19","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1038\/ncomms7791","volume":"6","author":"S Cheng","year":"2015","unstructured":"Cheng S, Larson MG, McCabe EL, Murabito JM, Rhee EP, Ho JE, et al. Distinct metabolomic signatures are associated with longevity in humans. Nat Commun. 2015;6:6791.","journal-title":"Nat Commun"},{"issue":"1","key":"1647_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/ije\/dyz211","volume":"49","author":"R Balasubramanian","year":"2020","unstructured":"Balasubramanian R, Paynter NP, Giulianini F, Manson JE, Zhao Y, Chen JC, et al. Metabolomic profiles associated with all-cause mortality in the women\u2019s health initiative. Int J Epidemiol. 2020;49(1):289\u2013300.","journal-title":"Int J Epidemiol"},{"issue":"20","key":"1647_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.120.050281","volume":"142","author":"M Nayor","year":"2020","unstructured":"Nayor M, Shah RV, Miller PE, Blodgett JB, Tanguay M, Pico AR, et al. Metabolic architecture of acute exercise response in middle-aged adults in the community. Circulation. 2020;142(20):1905\u201324.","journal-title":"Circulation"},{"issue":"1","key":"1647_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13073-022-01036-8","volume":"14","author":"MJ Gloudemans","year":"2022","unstructured":"Gloudemans MJ, Balliu B, Nachun D, Schnurr TM, Durrant MG, Ingelsson E, et al. Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes. Genome Med. 2022;14(1):31.","journal-title":"Genome Med"},{"issue":"5","key":"1647_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12263-014-0423-5","volume":"9","author":"B van Ommen","year":"2014","unstructured":"van Ommen B, van der Greef J, Ordovas JM, Daniel H. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr. 2014;9(5):423.","journal-title":"Genes Nutr"},{"issue":"8","key":"1647_CR24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.2337\/db12-0754","volume":"62","author":"JE Ho","year":"2013","unstructured":"Ho JE, Larson MG, Vasan RS, Ghorbani A, Cheng S, Rhee EP, et al. Metabolite profiles during oral glucose challenge. Diabetes. 2013;62(8):2689\u201398.","journal-title":"Diabetes"},{"key":"1647_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","volume":"110","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. Am J Epidemiol. 1979;110:281\u201390.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1647_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archinte.1979.03630450011006","volume":"139","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, Sorlie P. Some health benefits of physical activity. Arch Intern Med. 1979;139(8):857\u201361.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1647_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3945\/jn.111.157222","volume":"142","author":"SE Chiuve","year":"2012","unstructured":"Chiuve SE, Fung TT, Rimm EB, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009\u201318.","journal-title":"J Nutr"},{"issue":"9","key":"1647_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1647_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450\u20138.","journal-title":"Am J Cardiol"},{"issue":"14","key":"1647_CR30","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/CIRCULATIONAHA.109.914507","volume":"122","author":"GF Mitchell","year":"2010","unstructured":"Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, et al. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study. Circulation. 2010;122(14):1379\u201386.","journal-title":"Circulation"},{"issue":"23","key":"1647_CR31","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.jacc.2012.09.007","volume":"60","author":"CW Tsao","year":"2012","unstructured":"Tsao CW, Preis SR, Peloso GM, Hwang S-J, Kathiresan S, Fox CS, et al. Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study. J Am Coll Cardiol. 2012;60(23):2364\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1647_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2337\/dc08-1382","volume":"32","author":"EA Molenaar","year":"2009","unstructured":"Molenaar EA, Massaro JM, Jacques PF, Pou KM, Ellison RC, Hoffmann U, et al. Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the framingham heart study. Diabetes Care. 2009;32(3):505\u201310.","journal-title":"Diabetes Care"},{"key":"1647_CR33","unstructured":"Kannel W. The Framingham study: an epidemiological investigation of cardiovascular disease. Section 34. In: Framingham Heart Study, 30 year follow up, (editors). Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Bethesda, MD: National heart, lung, and blood institute. 1987."},{"issue":"25 Suppl 2","key":"1647_CR34","first-page":"S49","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/american heart association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S49-73.","journal-title":"Circulation"},{"issue":"2","key":"1647_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11892-022-01449-0","volume":"22","author":"DG Izundegui","year":"2022","unstructured":"Izundegui DG, Nayor M. Metabolomics of type 1 and type 2 diabetes: insights into risk prediction and mechanisms. Curr Diab Rep. 2022;22(2):65\u201376.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"1647_CR36","doi-asserted-by":"publisher","first-page":"e002977","DOI":"10.1161\/CIRCGEN.119.002977","volume":"13","author":"R Balasubramanian","year":"2020","unstructured":"Balasubramanian R, Demler O, Guasch-Ferre M, Paynter NP, Sheehan R, Liu S, et al. Metabolomic effects of hormone therapy and associations with coronary heart disease among postmenopausal women. Circ Genom Precis Med. 2020;13(6):e002977.","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"1647_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/gerona\/glx232","volume":"74","author":"A Yeri","year":"2019","unstructured":"Yeri A, Murphy RA, Marron MM, Clish C, Harris TB, Lewis GD, et al. Metabolite profiles of healthy aging index are associated with cardiovascular disease in african americans: the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci. 2019;74(1):68\u201372.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1647_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.08.004","author":"A Asadi Shahmirzadi","year":"2020","unstructured":"Asadi Shahmirzadi A, Edgar D, Liao CY, Hsu YM, Lucanic M, Asadi Shahmirzadi A, et al. Alpha-ketoglutarate an endogenous metabolite extends lifespan and compresses morbidity in aging mice. Cell Metab. 2020. https:\/\/doi.org\/10.1016\/j.cmet.2020.08.004.","journal-title":"Cell Metab"},{"key":"1647_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003755","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Hu FB, Ruiz-Canela M, Clish CB, Dennis C, Salas-Salvado J, et al. Metabolites of glutamate metabolism are associated with incident cardiovascular events in the PREDIMED PREvencion con DIeta MEDiterranea (PREDIMED) trial. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.116.003755.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"1647_CR40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.numecd.2019.06.005","volume":"29","author":"X Liu","year":"2019","unstructured":"Liu X, Zheng Y, Guasch-Ferre M, Ruiz-Canela M, Toledo E, Clish C, et al. High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: case-cohort study within the PREDIMED trial. Nutr Metab Cardiovasc Dis. 2019;29(10):1040\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"1647_CR41","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1096\/fj.11-198093","volume":"26","author":"S Krug","year":"2012","unstructured":"Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, et al. The dynamic range of the human metabolome revealed by challenges. FASEB J. 2012;26(6):2607\u201319.","journal-title":"FASEB J"},{"issue":"7","key":"1647_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamacardio.2019.1573","volume":"4","author":"JM Robbins","year":"2019","unstructured":"Robbins JM, Herzig M, Morningstar J, Sarzynski MA, Cruz DE, Wang TJ, et al. Association of dimethylguanidino valeric acid with partial resistance to metabolic health benefits of regular exercise. JAMA Cardiol. 2019;4(7):636\u201343.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"1647_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12916-019-1440-4","volume":"17","author":"Q Wang","year":"2019","unstructured":"Wang Q, Jokelainen J, Auvinen J, Puukka K, Keinanen-Kiukaanniemi S, Jarvelin MR, et al. Insulin resistance and systemic metabolic changes in oral glucose tolerance test in 5340 individuals: an interventional study. BMC Med. 2019;17(1):217.","journal-title":"BMC Med"},{"issue":"1","key":"1647_CR44","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.1038\/s41598-018-26701-0","volume":"8","author":"C Nowak","year":"2018","unstructured":"Nowak C, Hetty S, Salihovic S, Castillejo-Lopez C, Ganna A, Cook NL, et al. Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance. Sci Rep. 2018;8(1):8691.","journal-title":"Sci Rep"},{"issue":"12","key":"1647_CR45","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1210\/jc.2019-01104","volume":"104","author":"C Wildberg","year":"2019","unstructured":"Wildberg C, Masuch A, Budde K, Kastenmuller G, Artati A, Rathmann W, et al. Plasma metabolomics to identify and stratify patients with impaired glucose tolerance. J Clin Endocrinol Metab. 2019;104(12):6357\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"1647_CR46","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa054","author":"HB Beyene","year":"2020","unstructured":"Beyene HB, Hamley S, Giles C, Huynh K, Smith A, Cinel M, et al. Mapping the associations of the plasma lipidome with insulin resistance and response to an oral glucose tolerance test. J Clin Endocrinol Metab. 2020. https:\/\/doi.org\/10.1210\/clinem\/dgaa054.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1647_CR47","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.2337\/db21-0397","volume":"70","author":"R Li-Gao","year":"2021","unstructured":"Li-Gao R, Hughes DA, van Klinken JB, de Mutsert R, Rosendaal FR, Mook-Kanamori DO, et al. Genetic studies of metabolomics change after a liquid meal illuminate novel pathways for glucose and lipid metabolism. Diabetes. 2021;70(12):2932\u201346.","journal-title":"Diabetes"},{"issue":"3","key":"1647_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1210\/jc.2005-1005","volume":"91","author":"F Cavalot","year":"2006","unstructured":"Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi gonzaga diabetes study. J Clin Endocrinol Metab. 2006;91(3):813\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1647_CR49","doi-asserted-by":"publisher","first-page":"10280","DOI":"10.1096\/fj.201900148R","volume":"33","author":"IPG van Bussel","year":"2019","unstructured":"van Bussel IPG, Fazelzadeh P, Frost GS, Rundle M, Afman LA. Measuring phenotypic flexibility by transcriptome time-course analyses during challenge tests before and after energy restriction. FASEB J. 2019;33(9):10280\u201390.","journal-title":"FASEB J"},{"issue":"3","key":"1647_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12263-015-0459-1","volume":"10","author":"JHM Stroeve","year":"2015","unstructured":"Stroeve JHM, van Wietmarschen H, Kremer BHA, van Ommen B, Wopereis S. Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr. 2015;10(3):13.","journal-title":"Genes Nutr"},{"issue":"8","key":"1647_CR51","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes Metab Syndr. 2022;16(8):102581.","journal-title":"Diabetes Metab Syndr"},{"issue":"18","key":"1647_CR52","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125(18):2222\u201331.","journal-title":"Circulation"},{"issue":"2","key":"1647_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004525","volume":"4","author":"S Wopereis","year":"2009","unstructured":"Wopereis S, Rubingh CM, van Erk MJ, Verheij ER, van Vliet T, Cnubben NH, et al. Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes. PLoS ONE. 2009;4(2): e4525.","journal-title":"PLoS ONE"},{"issue":"10","key":"1647_CR54","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00125-016-4041-1","volume":"59","author":"T Fall","year":"2016","unstructured":"Fall T, Salihovic S, Brandmaier S, Nowak C, Ganna A, Gustafsson S, et al. Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes. Diabetologia. 2016;59(10):2114\u201324.","journal-title":"Diabetologia"},{"key":"1647_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/msb.2008.50","volume":"4","author":"O Shaham","year":"2008","unstructured":"Shaham O, Wei R, Wang TJ, Ricciardi C, Lewis GD, Vasan RS, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol. 2008;4:214.","journal-title":"Mol Syst Biol"},{"key":"1647_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1749-8090-5-106","volume":"5","author":"G Veres","year":"2010","unstructured":"Veres G, Radovits T, Seres L, Horkay F, Karck M, Szab\u00f3 G. Effects of inosine on reperfusion injury after cardiopulmonary bypass. J Cardiothorac Surg. 2010;5:106.","journal-title":"J Cardiothorac Surg"},{"issue":"2","key":"1647_CR57","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","volume":"164","author":"G Hasko","year":"2000","unstructured":"Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, et al. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol. 2000;164(2):1013\u20139.","journal-title":"J Immunol"},{"key":"1647_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2019.11.026","volume":"292","author":"W Li","year":"2020","unstructured":"Li W, Shu S, Cheng L, Hao X, Wang L, Wu Y, et al. Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions. Atherosclerosis. 2020;292:193\u2013200.","journal-title":"Atherosclerosis"},{"key":"1647_CR59","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0007502020","author":"S Miyazaki-Anzai","year":"2021","unstructured":"Miyazaki-Anzai S, Masuda M, Shiozaki Y, Keenan AL, Chonchol M, Kremoser C, et al. Free deoxycholic acid exacerbates vascular calcification in CKD through ER stress mediated ATF4 activation. Kidney360. 2021. https:\/\/doi.org\/10.34067\/KID.0007502020.","journal-title":"Kidney360"},{"issue":"1","key":"1647_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.numecd.2017.07.011","volume":"28","author":"K Paapstel","year":"2018","unstructured":"Paapstel K, Kals J, Eha J, Tootsi K, Ottas A, Piir A, et al. Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis. Nutr Metab Cardiovasc Dis. 2018;28(1):44\u201352.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"1647_CR61","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamacardio.2019.4130","volume":"4","author":"E Cavus","year":"2019","unstructured":"Cavus E, Karakas M, Ojeda FM, Kontto J, Veronesi G, Ferrario MM, et al. Association of circulating metabolites with risk of coronary heart disease in a european population: results from the biomarkers for cardiovascular risk assessment in Europe (BiomarCaRE) consortium. JAMA Cardiol. 2019;4(12):1270\u20139.","journal-title":"JAMA Cardiol"},{"issue":"12","key":"1647_CR62","doi-asserted-by":"publisher","first-page":"e1004801","DOI":"10.1371\/journal.pgen.1004801","volume":"10","author":"A Ganna","year":"2014","unstructured":"Ganna A, Salihovic S, Sundstrom J, Broeckling CD, Hedman AK, Magnusson PK, et al. Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease. PLoS Genet. 2014;10(12):e1004801.","journal-title":"PLoS Genet"},{"issue":"7","key":"1647_CR63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.tim.2011.05.006","volume":"19","author":"E Holmes","year":"2011","unstructured":"Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011;19(7):349\u201359.","journal-title":"Trends Microbiol"},{"issue":"10","key":"1647_CR64","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1194\/jlr.R200009-JLR200","volume":"43","author":"FB Kraemer","year":"2002","unstructured":"Kraemer FB, Shen WJ. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res. 2002;43(10):1585\u201394.","journal-title":"J Lipid Res"},{"issue":"18","key":"1647_CR65","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.18632\/aging.102281","volume":"11","author":"A Ho","year":"2019","unstructured":"Ho A, Sinick J, Esko T, Fischer K, Menni C, Zierer J, et al. Circulating glucuronic acid predicts healthspan and longevity in humans and mice. Aging (Albany NY). 2019;11(18):7694\u2013706.","journal-title":"Aging (Albany NY)"},{"issue":"7505","key":"1647_CR66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13264","volume":"510","author":"RM Chin","year":"2014","unstructured":"Chin RM, Fu X, Pai MY, Vergnes L, Hwang H, Deng G, et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature. 2014;510(7505):397\u2013401.","journal-title":"Nature"},{"issue":"6","key":"1647_CR67","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","volume":"24","author":"P Vallance","year":"2004","unstructured":"Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol. 2004;24(6):1023\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1647_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/gut.51.2.219","volume":"51","author":"J Tack","year":"2002","unstructured":"Tack J, Demedts I, Meulemans A, Schuurkes J, Janssens J. Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut. 2002;51(2):219\u201324.","journal-title":"Gut"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01647-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01647-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:03:40Z","timestamp":1665878620000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01647-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01647-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at Boston University Medical Campus\/Boston Medical Center and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In the past 12\u00a0months, Dr. Shah has served as a consultant for Myokardia (ongoing) and Best Doctors (ongoing), receives research funding from Amgen (concluded), had minor stock holdings in Gilead, and his spouse has current stock holdings in Pfizer. Dr. Shah is a co-inventor on a patent for ex-RNAs signatures of cardiac remodeling. Dr. Mitchell is owner of Cardiovascular Engineering, Inc., a company that designs and manufactures devices that measure vascular stiffness. The company uses these devices in clinical trials that evaluate the effects of diseases and interventions on vascular stiffness. Dr. Mitchell also serves as a consultant to and receives grants and honoraria from Novartis, Merck, Bayer, Servier, Philips and deCODE genetics. Dr. Nayor has served as a guest speaker\/consultant for Cytokinetics. All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}